Cryotherapy protocols for metastatic breast cancer after failure of radical surgery

Cryobiology

Volumn 67, Issue 1, 2013, Pages 17-22

  Niu, Lizhi ^a,b,c   Mu, Feng ^b,c   Zhang, Changming ^a   Li, Yongqiang ^a   Liu, Weiqun ^a   Jiang, Feng ^b   Li, Li ^c   Liu, Chunyan ^c   Zeng, Jianying ^a   yao, Fei ^a   Chen, Jibing ^a,c   Li, Jialiang ^a,b   Zuo, Jiansheng ^a,b   Xu, Kecheng ^a,b,c  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^b Fuda Institute of Cryosurgery for Cancer   (China)

^c GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

Author keywords

Chemotherapy; Cryo immunotherapy; Cryotherapy; Dendritic cell cytokine induced killer cell; Metastatic breast cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOPTIVE TRANSFER; ADULT; AGED; ARTICLE; BREAST METASTASIS; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CRYOABLATION; DENDRITIC CELL; FOLLOW UP; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT FAILURE; TUMOR RECURRENCE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; CRYOSURGERY; CRYOTHERAPY; CYTOKINE-INDUCED KILLER CELLS; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNOTHERAPY, ADOPTIVE; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LUNG NEOPLASMS; MIDDLE AGED; SKIN NEOPLASMS;

EID: 84879552985     PISSN: 00112240     EISSN: 10902392     Source Type: Journal    
DOI: 10.1016/j.cryobiol.2013.04.004     Document Type: Article

References (29)

1. Ali M.Y., Grimm C.F., Ritter M., Mohr L., Allgaier H.P., Weth R., Bocher W.O., Endrulat K., Blum H.E., Geissler M. Activation of dendritic cells by local ablation of hepatocellular carcinoma. J. Hepatol. 2005, 43:817-822.
2. Andre F., Slimane K., Bachelot T., Dunant A., Namer M., Barrelier A., Kabbaj O., Spano J.P., Marsiglia H., Rouzier R., Delaloge S., Spielmann M. Breast cancer with synchronous metastases: trends in survival during a 14-year period. J. Clin. Oncol. 2004, 22:3302-3308.
3. Chia S.K., Speers C.H., D'Yachkova Y., Kang A., Malfair-Taylor S., Barnett J., Coldman A., Gelmon K.A., O'Reilly E., Olivotto I.A. The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer. Cancer 2007, 110:973-979.
4. Cortazar P., Justice R., Johnson J., Sridhara R., Keegan P., Pazdur R. US food and drug administration approval overview in metastatic breast cancer. J. Clin. Oncol. 2012, 30:1705-1711.
5. Curigliano G., Spitaleri G., Pietri E., Rescigno M., de Braud F., Cardillo A., Munzone E., Rocca A., Bonizzi G., Brichard V., Orlando L., Goldhirsch A. Breast cancer vaccines: a clinical reality or fairy tale?. Ann. Oncol. 2006, 17:750-762.
6. den Brok M.H., Sutmuller R.P., Nierkens S., Bennink E.J., Frielink C., Toonen L.W., Boerman O.C., Figdor C.G., Ruers T.J., Adema G.J. Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity. Br. J. Cancer 2006, 95:896-905.
7. Eisenhauer E.A., Therasse P., Bogaerts J., Schwartz L.H., Sargent D., Ford R., Dancey J., Arbuck S., Gwyther S., Mooney M., Rubinstein L., Shankar L., Dodd L., Kaplan R., Lacombe D., Verweij J. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur. J. Cancer 2009, 45:228-247.
8. Gennari A., Conte P., Rosso R., Orlandini C., Bruzzi P. Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studies. Cancer 2005, 104:1742-1750.
9. Giordano S.H., Buzdar A.U., Smith T.L., Kau S.W., Yang Y., Hortobagyi G.N. Is breast cancer survival improving?. Cancer 2004, 100:44-52.
10. Goldberg S.N., Grassi C.J., Cardella J.F., Charboneau J.W., Dodd G.D., Dupuy D.E., Gervais D., Gillams A.R., Kane R.A., Lee F.T., Livraghi T., McGahan J., Phillips D.A., Rhim H., Silverman S.G. Image-guided tumor ablation: standardization of terminology and reporting criteria. J. Vasc. Interv. Radiol. 2005, 16:765-778.
11. Johnson J.R., Ning Y.M., Farrell A., Justice R., Keegan P., Pazdur R. Accelerated approval of oncology products: the food and drug administration experience. J. Natl. Cancer Inst. 2011, 103:636-644.
12. Li H., Wang C., Yu J., Cao S., Wei F., Zhang W., Han Y., Ren X.B. Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery. Cytotherapy 2009, 11:1076-1083.
13. Littrup P.J., Freeman-Gibb L., Andea A., White M., Amerikia K.C., Bouwman D., Harb T., Sakr W. Cryotherapy for breast fibroadenomas. Radiology 2005, 234:63-72.
14. Littrup P.J., Jallad B., Vorugu V., Littrup G., Currier B., George M., Herring D. Lethal isotherms of cryoablation in a phantom study: effects of heat load, probe size, and number. J. Vasc. Interv. Radiol. 2009, 20:1343-1351.
15. Lorusso G., Ruegg C. New insights into the mechanisms of organ-specific breast cancer metastasis. Semin. Cancer Biol. 2012, 22:226-233.
16. Mauri D., Polyzos N.P., Salanti G., Pavlidis N., Ioannidis J.P. Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer. J. Natl. Cancer Inst. 2008, 100:1780-1791.
17. Nakamura M., Wada J., Suzuki H., Tanaka M., Katano M., Morisaki T. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer. Anticancer Res. 2009, 29:831-836.
18. Noguchi M., Nakano Y., Ohno Y., Kosaka T. Local therapy and survival in breast cancer with distant metastases. J. Surg. Oncol. 2012, 105:104-110.
19. Pfleiderer S.O., Freesmeyer M.G., Marx C., Kuhne-Heid R., Schneider A., Kaiser W.A. Cryotherapy of breast cancer under ultrasound guidance. initial results and limitations. Eur. Radiol. 2002, 12:3009-3014.
20. Pfleiderer S.O., Marx C., Camara O., Gajda M., Kaiser W.A. Ultrasound-guided, percutaneous cryotherapy of small (< or =15mm) breast cancers. Invest. Radiol. 2005, 40:472-477.
21. Plate J. Clinical trials of vaccines for immunotherapy in pancreatic cancer. Expert Rev. Vaccines 2011, 10:825-836.
22. Rabbani S.A., Mazar A.P. Evaluating distant metastases in breast cancer: from biology to outcomes. Cancer Metastasis Rev. 2007, 26:663-674.
23. Rovere-Querini P., Manfredi A.A. Tumor destruction and in situ delivery of antigen presenting cells promote anti-neoplastic immune responses: implications for the immunotherapy of pancreatic cancer. JOP 2004, 5:308-314.
24. Sabel M.S., Kaufman C.S., Whitworth P., Chang H., Stocks L.H., Simmons R., Schultz M. Cryoablation of early-stage breast cancer: work-in-progress report of a multi-institutional trial. Ann. Surg. Oncol. 2004, 11:542-549.
25. Schueller G., Stift A., Friedl J., Dubsky P., Bachleitner-Hofmann T., Benkoe T., Jakesz R., Gnant M. Hyperthermia improves cellular immune response to human hepatocellular carcinoma subsequent to co-culture with tumor lysate pulsed dendritic cells. Int. J. Oncol. 2003, 22:1397-1402.
26. Smith N.Z. Treating metastatic breast cancer with systemic chemotherapies: current trends and future perspectives. Clin. J. Oncol. Nurs. 2012, 16:E33-E43.
27. Valastyan S., Weinberg R.A. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011, 147:275-292.
28. Wright S.E. Immunotherapy of breast cancer. Expert Opin. Biol. Ther. 2012, 12:479-490.
29. Zwaveling S., Ferreira Mota S.C., Nouta J., Johnson M., Lipford G.B., Offringa R., van der Burg S.H., Melief C.J. Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides. J. Immunol. 2002, 169:350-358.